COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review

Coronavirus disease 2019 (COVID-19) pandemic has affected more than 40 million people worldwide. Some patients had episodes of symptom recurrence after the first episode of infection with variable intervals. There are multiple issues and hypotheses about re-infection or re-activation of the virus, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tehrani, H.A., Darnahal, M., Nadji, S.A., Haghighi, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777517/
https://www.ncbi.nlm.nih.gov/pubmed/33425365
http://dx.doi.org/10.1016/j.nmni.2020.100830
_version_ 1783630920462368768
author Tehrani, H.A.
Darnahal, M.
Nadji, S.A.
Haghighi, S.
author_facet Tehrani, H.A.
Darnahal, M.
Nadji, S.A.
Haghighi, S.
author_sort Tehrani, H.A.
collection PubMed
description Coronavirus disease 2019 (COVID-19) pandemic has affected more than 40 million people worldwide. Some patients had episodes of symptom recurrence after the first episode of infection with variable intervals. There are multiple issues and hypotheses about re-infection or re-activation of the virus, especially in immunocompromised patients. In this paper, we present details of an individual with a recent history of COVID-19 who proceeded to acute myeloid leukaemia M3 and immunosuppression by chemotherapy, then we review some recently published articles about possible re-infection or re-activation.
format Online
Article
Text
id pubmed-7777517
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77775172021-01-07 COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review Tehrani, H.A. Darnahal, M. Nadji, S.A. Haghighi, S. New Microbes New Infect Mini-Review Coronavirus disease 2019 (COVID-19) pandemic has affected more than 40 million people worldwide. Some patients had episodes of symptom recurrence after the first episode of infection with variable intervals. There are multiple issues and hypotheses about re-infection or re-activation of the virus, especially in immunocompromised patients. In this paper, we present details of an individual with a recent history of COVID-19 who proceeded to acute myeloid leukaemia M3 and immunosuppression by chemotherapy, then we review some recently published articles about possible re-infection or re-activation. Elsevier 2020-12-05 /pmc/articles/PMC7777517/ /pubmed/33425365 http://dx.doi.org/10.1016/j.nmni.2020.100830 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mini-Review
Tehrani, H.A.
Darnahal, M.
Nadji, S.A.
Haghighi, S.
COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review
title COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review
title_full COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review
title_fullStr COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review
title_full_unstemmed COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review
title_short COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review
title_sort covid-19 re-infection or persistent infection in patient with acute myeloid leukaemia m3: a mini review
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777517/
https://www.ncbi.nlm.nih.gov/pubmed/33425365
http://dx.doi.org/10.1016/j.nmni.2020.100830
work_keys_str_mv AT tehraniha covid19reinfectionorpersistentinfectioninpatientwithacutemyeloidleukaemiam3aminireview
AT darnahalm covid19reinfectionorpersistentinfectioninpatientwithacutemyeloidleukaemiam3aminireview
AT nadjisa covid19reinfectionorpersistentinfectioninpatientwithacutemyeloidleukaemiam3aminireview
AT haghighis covid19reinfectionorpersistentinfectioninpatientwithacutemyeloidleukaemiam3aminireview

Ejemplares similares